However, aberrant activation of Cdk5 is believed to be associated with the pathogenesis of several neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). This evidence concerns the gene CDK5 and early-onset autosomal dominant Alzheimer disease.